Expression of the BRCA2 and XPD genes in tumour tissue of HNSCC patients declined progressively as the cancer stage advanced, was reverse that of the NAT, but was mirrored by the expression in the blood. The gene discussed is BRD2; the disease is head and neck squamous cell carcinoma.